Le Lézard
Classified in: Health, Science and technology
Subject: Economic News/Analysis

Global Sleep Apnea Devices Market (2021 to 2026) - Growing Demand For Home Sleep Apnea Tests Presents Opportunities - ResearchAndMarkets.com


The "Sleep Apnea Devices Market by Type, Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces, Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) - Global Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.

The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.

Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market. In contrast, the high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls are expected to limit market growth to a certain extent during the forecast period. The sleep apnea devices market is segmented based on type, end user and region.

Therapeutic devices accounted for the largest share of the Sleep Apnea Devices Market and is expected to grow at the highest CAGR in the forecast period.

Based on type, the sleep apnea devices market is segmented into therapeutic and diagnostic devices. The therapeutic devices segment accounted for the largest market share and is also expected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the expanding pool of diagnosed sleep apnea patients, increasing adoption of sleep apnea therapeutic devices, and the improving reimbursement scenario for these devices.

Sleep laboratories & hospitals account for the largest share of the Sleep Apnea Devices Market in 2020.

The home care settings/individuals' segment is expected to grow at the fastest rate during the forecast period. Based on end users, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the sleep apnea devices market. However, the home care settings/individuals' segment is estimated to grow at the highest CAGR during the forecast period. The increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

North America will dominate the market during the forecast period.

Geographically, the sleep apnea devices market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of the sleep apnea devices market. The large share of the North American market can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/58g82z


These press releases may also interest you

at 22:00
MedMira Inc. (MedMira) , reported today on its financial results for the financial year ended July 31, 2021. Profit and Loss Highlights Revenue: The Company recorded revenues in FY2021 of $2,060,497 compared to $588,836 in FY2020. The increase in...

at 22:00
Deep Bio, a leading AI biotech dedicated to cancer diagnosis, announced that it has entered into a collaboration agreement with Paris-based digital pathology leader, Tribun Health. Under the agreement, the two companies will harness the power of AI...

at 21:00
Nikon Instruments Inc., innovator of advanced microscope systems today announced the release of the AX R MP multiphoton confocal microscope, which can acquire high resolution, large field of view images, deep within living organisms at high speed....

at 20:56
A group of six pharmacy organizations today criticized the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to only "encourage" but not require payment to pharmacists for testing, patient assessment, ordering/prescribing and...

at 20:00
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly update on the status of the management...

at 19:55
Ahead of the oral arguments in Dobbs v. Jackson Women's Health Center, the first direct challenge to Roe v. Wade in a generation, Family Research Council published a new comprehensive issue brief identifying the United States as one of only six...



News published on 22 october 2021 at 11:35 and distributed by: